ADI — Analog Devices, Inc.

Wall Street remains overwhelmingly positive: 45 Buy ratings vs 9 Hold and a consensus price target of ~$480. The market is rewarding ADI's strong Q3 FY2026 beat (revenue $4.02B, adjusted EPS $3.45), upbeat Q4 guidance (~$4.3B revenue), and the September 9, 2026 Alif Semiconductor acquisition that bolsters its edge-AI story. However, the stock's 3-month decline of 9.34% shows some valuation caution despite the fundamental strength.

ADI is in a clear cyclical upturn. Revenue bottomed at $2.16B in Q2 FY2024 and has since accelerated to $4.02B in Q3 FY2026 (+86% from trough, +39.6% YoY). Gross margin expanded from 54.6% in Q2 FY2024 to 67.3% in Q3 FY2026, and operating margin rose from 17.9% to 40.1% over the same period. Diluted EPS grew from $0.61 to $2.74. The acceleration is driven by industrial and data center demand, not a one-off blip—sequential revenue has risen for six consecutive quarters.

As of 2026-09-13, ADI trades at 44.7x TTM P/E (vs. 5-year average 44.1x) and 13.3x TTM P/S (vs. 5-year average 8.9x), so it is rich on trailing metrics. However, the forward P/E is ~29.4x based on next-FY EPS of $12.868, which is more reasonable given expected ~52% EPS growth. PEG of 0.39 suggests undervaluation relative to growth if that growth is sustainable. Overall: expensive vs. its own history, but not unreasonable on forward earnings.

The stock has already priced in a strong recovery: it trades above its 200-day SMA and near its historical trailing P/E. The key question is whether ADI can deliver the guided Q4 revenue of ~$4.3B and EPS of $3.86, and then set up another year of growth for FY2027. If it beats and raises again on November 24, 2026, the forward multiple could compress and justify higher prices. If growth stalls or guidance disappoints, the rich P/S multiple leaves downside risk. Watch the Q4 report closely.

As of 2026-09-13, RSI is 56.1—neutral, neither overbought nor oversold. Price ($378.78) sits 2.58% above the 20-day SMA, 0.89% above the 50-day SMA, and 7.9% above the 200-day SMA, confirming a longer-term uptrend. The 1-week return is +4.56%, but the 3-month return is -9.34%, indicating a consolidation phase. The recent bounce off the 50-day SMA is constructive, but the stock is not at a deep-value entry point; a pullback toward $350–$360 would offer better risk/reward.

• AI infrastructure and edge computing: ADI's analog/mixed-signal and edge-AI chips (boosted by the Alif acquisition) are capturing the second wave of AI hardware demand beyond data-center GPUs.
• Cyclical recovery in industrial and automotive: inventory destocking has largely cleared, and capex is resuming, supporting ADI's core end markets.
• Interest rate cuts: loosening financial conditions could accelerate industrial automation and capital spending, benefiting ADI's customers.
• Semiconductor supply chain and geopolitics: export controls, China exposure, and foundry capacity constraints remain ongoing risks.
• High-multiple sensitivity to macro tech corrections: with P/S at 13.3x, ADI is vulnerable to any shift in AI sentiment or rate expectations.

• Q4 FY2026 earnings on November 24, 2026: fiscal year-end results and initial FY2027 outlook.
• Alif Semiconductor acquisition integration: $1.35B deal announced September 9, 2026, to accelerate edge-AI 'Physical Intelligence' strategy.
• CFO presentation at J.P. Morgan U.S. All Stars Conference on September 22, 2026, may provide margin and integration details.
• Continued data center and industrial demand recovery, particularly in AI-driven automation and robotics.

• Rich valuation: P/S 13.3x vs. 5-year average 8.9x, and P/E 44.7x, leaving little margin for error if growth slows.
• Cyclical downturn: semiconductor demand is cyclical; a macro slowdown could quickly reverse the current recovery.
• Integration and execution risk from the Alif acquisition, including potential dilution and R&D spending pressure.
• Competitive pressure in analog/mixed-signal and edge AI from larger peers and startups.
• Customer concentration and end-market cyclicality in industrial and automotive.

ADI is a high-quality compounder with accelerating revenue, expanding margins, strong free cash flow ($4.9B TTM), and a fortress balance sheet. The Alif acquisition adds a promising edge-AI growth vector. However, the stock already reflects much of the recovery, trading at a premium P/S and near its historical trailing P/E. The forward P/E of ~29x is reasonable if the company delivers on its growth guidance, but there is limited margin of safety. I'd be a buyer on meaningful pullbacks, not chase at current levels.

Applied a 33x forward P/E to next-FY consensus EPS of $12.868, justified by ADI's high margins, strong FCF, and expected ~52% EPS growth, while tempering for cyclicality and rich historical P/S. 33 × 12.868 = $424.64.